Project Details
| Status | Active |
|---|---|
| Effective start/end date | 10/10/23 → 10/10/26 |
Funding
- Medpace Clinical Research LLC (Prot #Ph2 INBRX-109 SA CS // Prot #Ph2 INBRX-109 SA CS)
- Inhibrx, Inc. (Prot #Ph2 INBRX-109 SA CS // Prot #Ph2 INBRX-109 SA CS)
Prot #Ph2 INBRX‐109 SA CS: A Randomized, Blinded, Placebo‐controlled, Phase 2 Study of INBRX‐109 in Unresectable or Metastatic Conventional Chondrosarcoma
- Pollack, Seth Michaels (PD/PI)
Project: Research project